Skip to main content
. 2013 Mar 1;2(3):e23472. doi: 10.4161/onci.23472

Table 2. Patients’ characteristics and ratio cluster.

Characteristics #Low C
(n = 40)		 #Low B
(n = 15)		 #High C
(n = 28)		 Statistics  
Sex*
  
  
  
  
 p1
  
  
Men
 30 (75%)
 11 (73%)
 22 (79%)
  
 0.89
  
  
Women
 10 (25%)
 4 (27%)
 6 (21%)
  
  
  
  
Mode of transmission*
  
Men from Men
 27 (68%)
 11 (73%)
 19 (68%)
  
 0.87
  
  
Men from Women
 3 (8%)
 0 (0%)
 3 (11%)
  
  
  
  
Women from Men
 10 (25%)
 4 (27%)
 6 (21%)
  
  
  
  
Time (in months) from infection to**
  
 p2
  
  
Inclusion
 6.0 [1.3–43.5]
 6.8 [1.8–35.5]
 6.6 [1.3–36.5]
  
 0.72
  
  
NKp30 study
 38.7 [4.7–44.3]
 35.5 [10–44]
 39.2 [3.6–44.4]
  
 0.75
  
  
Biological markers**
  
  
  
 p2
  
 p3
  
At inclusion
  
  
  
  
  
  
  
CD4+ cells
 485.5 [202–987]
 874 [415–1330]
 542 [72–1193]
 < 0.01
  
 < 0.01a
  
Log(HIV-1 RNA)
 4.2 [3.4–5.6]
 3.5 [2.4–4.9]
 4.1 [2.9–5.5]
 0.06
  
 0.02a
  
Log(HIV-1 DNA)
 3 [1.8–4]
 2.6 [1.7–3.2]
 2.7 [1.7–3.5]
 0.17
  
 0.16a
  
At NKp30 status assessment
  
CD4+ cells
 457.5 [19–987]
 578 [305–940]
 488 [72–1193]
 0.16
  
 0.09b
  
Log(HIV-1 RNA)
 4 [3–5.6]
 3.7 [3.1–5]
 4 [2.7–5.4]
 0.62
  
 0.33b
  
Log(HIV-1 DNA) 3.2 [1.6–5.2] 2.6 [1.7–3.5] 2.9 [1.9–3.7] 0.14   0.10b  

# Ratio cluster groups; *number (%); ** median [min-max]; 1Fisher’s exact test; 2Kruskal-Wallis rank sum test; 3Linear regression adjusted for: amean time from contamination to inclusion in the study, bmean time from contamination to NKp30 status assessment.